(Q42635758)

English

Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients

scientific article published on October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients (English)

1 reference

Europe PubMed Central

4 November 2017

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Choy EH

1

1 reference

Europe PubMed Central

4 November 2017

Connolly DJ

2

1 reference

Europe PubMed Central

4 November 2017

Rapson N

3

1 reference

Europe PubMed Central

4 November 2017

Jeal S

4

1 reference

Europe PubMed Central

4 November 2017

Brown JC

5

1 reference

Europe PubMed Central

4 November 2017

Kingsley GH

6

1 reference

Europe PubMed Central

4 November 2017

Panayi GS

7

1 reference

Europe PubMed Central

4 November 2017

Johnston JM

8

1 reference

Europe PubMed Central

4 November 2017

publication date

1 October 2000

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

39

1 reference

Europe PubMed Central

4 November 2017

10

1 reference

Europe PubMed Central

4 November 2017

1139-1146

1 reference

Europe PubMed Central

4 November 2017

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Interferon-gamma

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Induction of tolerance in peripheral T cells with monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Induction of tolerance by monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Reshaping a therapeutic CD4 antibody

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.10.1139

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/39.10.1139

1 reference

Europe PubMed Central

4 November 2017

release_cxv5d3txqzfalaasroyw3vwgaq

1 reference

https://api.fatcat.wiki/v0/release/cxv5d3txqzfalaasroyw3vwgaq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42635758&oldid=2143965088"